ProfileGDS5678 / 1449586_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 22% 24% 23% 21% 23% 23% 28% 23% 30% 23% 23% 24% 23% 23% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.5503122
GSM967853U87-EV human glioblastoma xenograft - Control 22.5468524
GSM967854U87-EV human glioblastoma xenograft - Control 32.5329523
GSM967855U87-EV human glioblastoma xenograft - Control 42.4456521
GSM967856U87-EV human glioblastoma xenograft - Control 52.4917923
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.6082623
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.6869228
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.5225623
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.6647230
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.5314523
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.5239423
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.5261824
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.5361923
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.5312523